1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Collaborative Cancer Research Seed Grant" is currently closed and not accepting applications.
Collaborative Cancer Research Seed Grant is sponsored by Georgia CORE (Center for Oncology Research and Education). This grant supports research aimed at improving treatment for aggressive forms of endometrial cancer, specifically uterine serous carcinoma (USC). The project seeks to identify new treatment strategies for this rare but highly aggressive subtype of endometrial cancer.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Georgia CORE announces 2025 collaborative research seed grant winning team In an effort to give you the best possible service, we would be grateful if you could take a few minutes of your time to answer a few questions. Georgia's Online Cancer Information Center Georgia CORE announces 2025 collaborative research seed grant winning team May is National Cancer Research Month, and Georgia CORE is celebrating by awarding a research grant.
The “Collaborative Seed Grant Program for Cancer Research” provides seed funding for a cancer research project that involves two or more institutions or organizations in Georgia comprised of a lead and a collaborative research entity.
The 4th annual seed fund grant is going to Ali Arbab, MD, PhD of the Georgia Cancer Center at the Medical College of Georgia, Augusta University and Mujibur Khan, PhD of Georgia Southern University. The two will be awarded $100,000 to study multi-drug nanocapsules for breast cancer treatment. “Most breast cancer related mortality is due to recurrence and distal metastasis,” said Dr. Arbab.
“The tumor microenvironment, especially tumor associated macrophages, are shown to be prognostic factors in breast cancers, and with standard chemotherapy, can contribute to reviving the tumor. We will test nanocapsules to sustain release of an active drug that will more effectively impact the microenvironment of the tumor.
” The collaborative seed grant comes from the Georgia Cancer Research Fund, which is administered by Georgia CORE and funded by Georgia taxpayers who elect to donate on their tax forms. “This kind of cutting-edge research is what changes the lives of people impacted by cancer,” said Georgia CORE president Lynn Durham, EdD.
“Georgia taxpayers make a quick and easy decision to give to the cancer research fund, and we are grateful to be able to grant those funds directly to this life-saving research. ” Media, News & Events Home Events, Meetings & Conferences Past Meetings & Conferences Hearts Aligned Integrative Educational Conference This gathering is more than a conference.
It is a coming together of medical professionals, integrative practitioners, community leaders, sponsors, and advocates who believe cancer care should include the whole person — body, mind, and spirit. Together, we are creating space for education, empowerment, and expanded access to integrative services for cancer patients, survivors, and caregivers.
Strange seats bring colon cancer awareness to Georgia bars, coffee shops The AJC covers Georgia CORE's unique colon cancer awareness campaign, Weird Looking Stools, helping to raise awareness to look for the signs and symptoms of colon cancer. Our email newsletter allows you to get the most up-to-date information right in your Inbox.
Clinical Trials & Providers Screening Guidelines for Common Cancers Free Colon Cancer Screenings Breast & Ovarian Cancer Screening Tool Breast Cancer License Plate Fund Learn about new treatments Do you want help finding a clinical trial?
Efforts to expandclinical trials in Georgia For Healthcare Professionals Georgia Cancer Organizations Georgia's Comprehensive Cancer Control Plan Publications, Presentations & Reports Cancer Patient Navigators of Georgia Clinical Trials Navigator Program Georgia CORE reduces the burden of cancer in our state through research, education, and advocacy.
According to the current listing, eligibility includes: Not explicitly stated, but awarded to Mercer University School of Medicine in collaboration with Morehouse School of Medicine in the example provided. Confirm the full requirements in the official notice before applying.
The current listing shows $100,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was July 30, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Collaborative Cancer Research Seed Grant is funded by Georgia CORE (Center for Oncology Research and Education). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Future CoRe (NSF 25-543) advertises $280 million and 400 to 600 awards across 11 programs, with a September 10, 2026 target date. The directorate behind it is running 43 percent below its own four-year average, $1 billion of NSF's budget is locked in a central account, and the two-proposal cap is enforced with no exceptions. Here is how to read the gap between what the solicitation promises and what the directorate is actually paying for.
Read articleNSF 26-517 replaces the core solicitations of Environmental Biology, Integrative Organismal Systems and Molecular and Cellular Biosciences with a single directorate-wide opportunity. Proposals are accepted anytime, sorted centrally by NSF rather than targeted by the PI, and reorganized under three inquiry areas. Here is what the $280 million actually buys, why the loss of program targeting cuts both ways, and what to do before the September 16 webinar.
Read articleOn August 17, 2026, NSF released 12 new notices of funding opportunity worth over $1.5 billion across BIO, CISE, ENG, GEO and all five MPS divisions. The headline is the money. The structural change is that most of these solicitations say Proposals Accepted Anytime — replacing hard deadlines with soft target dates, consolidating dozens of program descriptions into single directorate-wide NOFOs, and quietly moving the competitive pressure from the calendar to the queue.
Read article